Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728819 · ClinicalTrials.gov registry record · NA
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
A NA study of Venous Thrombosis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 339
- Enrollment target
- 1
- Study location
NCT00728819: Completed NA study of Venous Thrombosis, sponsored by University of Pennsylvania.
NCT00728819 is a NA study of Venous Thrombosis that has completed, run by University of Pennsylvania. The registered enrollment target is 339 participants, below the 1,087-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00728819, a NA study of Venous Thrombosis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 339 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two different marketed PICC (peripherally inserted central catheter) designs. Clotting rates, procedural bleeding and ease of catheter insertion will be compared. It is hypothesized that the non-tapered design has a lower clotting rate and is easier to place than the tapered design. Bleeding rates are expected to be about the same.
Primary Outcome
Number participants with vein thrombosis
Conditions Studied
Interventions
- DEVICE Tapered PICC
- DEVICE Non-tapered PICC
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 339 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT00728819 record still lists
NCT00728819 is an interventional study that assigns participants to a tested intervention. The registered 339 participants enrollment target is mid-sized for trials with a published cap, below the 1,087-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Tapered PICC is the first listed.
NCT00728819 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00728819 about?
NCT00728819 is a clinical study titled "Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters". The purpose of this study is to compare two different marketed PICC (peripherally inserted central catheter) designs. Clotting rates, procedural bleeding and ease of catheter insertion will be compared. It is hypothesized that the non-tapered design has a lower clotting rate and is easier to place t...
What is the current status of trial NCT00728819?
This trial is currently completed. It is a NA study. The enrollment target is 339 participants. The study started on 2008-08. Estimated completion is 2011-08.
What conditions does trial NCT00728819 study?
This clinical trial studies the following conditions: Venous Thrombosis.
What interventions are being tested in trial NCT00728819?
The interventions under investigation include: Tapered PICC (DEVICE), Non-tapered PICC (DEVICE).
Who is sponsoring clinical trial NCT00728819?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00728819 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00728819's enrollment target sits among peer trials
339 5th of 9 higher than 5 of 9 other Venous Thrombosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
COMPLETED · NA
-
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
COMPLETED · NA
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia